Cross-Sectional Study of 285 Traditional Kratom Users in Thailand Finds No Clinically Significant Liver or Blood Toxicity

Why it matters

Much of the Western concern about kratom liver toxicity comes from case reports involving polysubstance use or contaminated products. This community-based study from kratom's home region provides a different lens — examining what chronic, traditional kratom use actually does to organ function in real-world users.

The big picture

Kratom has been used for centuries in Southeast Asia, yet most safety data come from Western case reports, which tend to over-represent adverse events and may not reflect typical use. Controlled community studies from endemic regions offer a cleaner signal. This study from Southern Thailand — where kratom grows natively and is used traditionally — directly compared organ function in matched users and non-users from the same population.

Key findings

• 285 traditional kratom users and 296 matched non-user controls from the same community in Southern Thailand were studied in this cross-sectional design
• After adjusting for confounders (age, sex, BMI, smoking, alcohol), no clinically significant differences in liver enzymes or blood parameters were found between groups
• Both groups maintained values within normal clinical reference ranges for hepatic and hematological markers
• Kratom users had lower serum creatinine and higher eGFR, but this was explained by lower BMI in the user group — not a direct effect of kratom
• Stratified analyses by duration and quantity of kratom use revealed no clear dose-response relationship for organ toxicity

What they say

The authors concluded that "within a traditional-use setting, chronic kratom consumption was not associated with clinically significant hepatic or hematological toxicity," emphasizing that lifestyle and demographic confounders must be carefully controlled when evaluating kratom's health impacts.

Bottom line

A well-controlled Thai community study found no liver or blood damage from chronic kratom use, reinforcing that the product type, dose, and user population matter greatly when evaluating kratom safety.